NO20084274L - Fremgangsmate for a opprettholde, forbedre og a gjenopprette bruskfenotypen av kondrocytter - Google Patents

Fremgangsmate for a opprettholde, forbedre og a gjenopprette bruskfenotypen av kondrocytter

Info

Publication number
NO20084274L
NO20084274L NO20084274A NO20084274A NO20084274L NO 20084274 L NO20084274 L NO 20084274L NO 20084274 A NO20084274 A NO 20084274A NO 20084274 A NO20084274 A NO 20084274A NO 20084274 L NO20084274 L NO 20084274L
Authority
NO
Norway
Prior art keywords
chondrocytes
restoring
maintaining
procedures
improving
Prior art date
Application number
NO20084274A
Other languages
English (en)
Norwegian (no)
Inventor
Andreas Knipper
Paula Muir-Mcleod
Original Assignee
Tigenix Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tigenix Nv filed Critical Tigenix Nv
Publication of NO20084274L publication Critical patent/NO20084274L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1317—Chondrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
NO20084274A 2006-03-20 2008-10-13 Fremgangsmate for a opprettholde, forbedre og a gjenopprette bruskfenotypen av kondrocytter NO20084274L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78398606P 2006-03-20 2006-03-20
PCT/EP2007/002452 WO2007107330A2 (fr) 2006-03-20 2007-03-20 Methodes permettant de preserver, ameliorer et restaurer le phenotype cartilagineux des chondrocytes

Publications (1)

Publication Number Publication Date
NO20084274L true NO20084274L (no) 2008-12-12

Family

ID=38057770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084274A NO20084274L (no) 2006-03-20 2008-10-13 Fremgangsmate for a opprettholde, forbedre og a gjenopprette bruskfenotypen av kondrocytter

Country Status (11)

Country Link
US (1) US20100028308A1 (fr)
EP (2) EP2004806A2 (fr)
JP (1) JP2009530334A (fr)
CN (1) CN101432419A (fr)
AU (1) AU2007229009A1 (fr)
CA (1) CA2646488A1 (fr)
IL (1) IL194175A0 (fr)
NO (1) NO20084274L (fr)
NZ (2) NZ589814A (fr)
RU (1) RU2008141279A (fr)
WO (1) WO2007107330A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110022706A (ko) * 2008-06-26 2011-03-07 케이씨아이 라이센싱 인코포레이티드 감압 치료 및 연골세포를 사용한 연골 형성의 자극
BR112012026924A2 (pt) 2010-04-21 2016-07-12 Basf Coatings Gmbh agente de revestimento com alto teor de corpo sólido e bom nivelamento, bem como laqueamentos de multicamadas produzidos desse e seu uso
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
EP2626410A1 (fr) * 2012-02-08 2013-08-14 Technische Hochshule Mittelhessen Dispositif et procédé d'expansion et de récolte de lignées cellulaires adhérentes
US20160235837A1 (en) * 2013-10-16 2016-08-18 Samuel Bogoch THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR MIDDLE EAST RESPIRATORY SYNDROME VIRUS (MERS CoV)
WO2015188020A1 (fr) * 2014-06-06 2015-12-10 Vivoscript, Inc. Méthode de réparation de lésion cartilagineuse
CA2986702C (fr) 2015-05-21 2023-04-04 David Wang Fibres osseuses corticales demineralisees modifiees
EP3417888A1 (fr) 2017-06-25 2018-12-26 co.don AG Procédé de fabrication de cartilages transplantables
TW201938788A (zh) * 2018-03-06 2019-10-01 美商歐瑞３恩公司 用於軟骨修復之源自iPSC之細胞組合物及相關系統與方法
EP3744831A1 (fr) * 2019-05-31 2020-12-02 co.don AG Procédé pour la culture de cartilage et sphéroïdes associés

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68218A (en) 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US5041138A (en) 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
US4846835A (en) 1987-06-15 1989-07-11 Grande Daniel A Technique for healing lesions in cartilage
US5053050A (en) 1988-04-29 1991-10-01 Samuel Itay Compositions for repair of cartilage and bone
US4904259A (en) 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
EP1282690B9 (fr) 1999-10-06 2005-03-02 Tigenix N.V. Isolement de cellules precurseurs et leur utilisation dans la reparation de tissus
DE20023659U1 (de) 1999-10-06 2005-07-07 Tigenix N.V. Molekulare Marker zum Testen der phänotypischen Stabilität von Zellpopulationen und Zellpopulationen für die autologe Transplantation
US6610535B1 (en) * 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
CZ20032082A3 (cs) * 2001-01-31 2003-11-12 Interface Biotech A/S Zlepšený způsob kultivace savčích buněk in vitro pro autologní způsoby implantace a transplantace

Also Published As

Publication number Publication date
WO2007107330A2 (fr) 2007-09-27
JP2009530334A (ja) 2009-08-27
RU2008141279A (ru) 2010-04-27
AU2007229009A1 (en) 2007-09-27
NZ589814A (en) 2012-03-30
WO2007107330A3 (fr) 2007-11-08
US20100028308A1 (en) 2010-02-04
CN101432419A (zh) 2009-05-13
EP2004806A2 (fr) 2008-12-24
EP2138196A1 (fr) 2009-12-30
IL194175A0 (en) 2011-08-01
CA2646488A1 (fr) 2007-09-27
NZ572055A (en) 2011-11-25

Similar Documents

Publication Publication Date Title
NO20084274L (no) Fremgangsmate for a opprettholde, forbedre og a gjenopprette bruskfenotypen av kondrocytter
WO2008060788A3 (fr) Compositions, procédés, et dispositifs destinés à traiter les maladies hépatiques
WO2008155659A3 (fr) Compositions pour prévenir ou traiter des défauts cutanés et leurs procédés d'utilisation
ES2572214T3 (es) Métodos para expansión celular y usos de células y medios acondicionados producidos de este modo para terapia
DK1476562T3 (da) Overekspression af extremozymgener i pseudomonas og nært beslægtede bakterier
WO2009092005A3 (fr) Procédés de génération de cardiomyocytes et progéniteurs cardiaques et compositions
WO2006070370A3 (fr) Systemes de culture de cellules souches
MX344970B (es) Medio de cultivo celular para la expresion de la proteina adamts.
WO2010086856A3 (fr) Procédés de génération de tissu à l'aide de matrices d'échafaudages acellulaires et dévitalisés provenant de micro-organes
WO2008064116A3 (fr) Procédé pour éviter ou traiter les rejets lors de transplantations d'organes, de cellules souches hématopoïétiques ou de moelle osseuse
WO2010033920A3 (fr) Compositions et procédés pour améliorer la reprogrammation d'une cellule
DK2173861T3 (da) Fremgangsmåder til behandling af et cellekulturmedium til anvendelse i en bioreaktor
WO2010124142A3 (fr) Compositions cellulaires issues de cellules reprogrammées dédifférenciées
WO2008024640A3 (fr) 'échafaudages' élastomères biodégradables contenant des cellules microintégrées
WO2008004990A3 (fr) Procédé de culture de cellules souches et cellules souches ainsi obtenues
MX2010004674A (es) Variantes de alfa-amilasa con propiedades alteradas.
AR058986A1 (es) Dominios de epsp sintetasa que confieren resistencia al glifosato
GB2446525A (en) Stem cell culture medium and method
WO2009007852A3 (fr) Cellules multipotentes/pluripotentes et procédés s'y rapportant
MX339769B (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
CY1119382T1 (el) Φυσικα βλαστοκυτταρα γελης toy wharton και καθαρισμος αυτων
DK2089516T3 (da) Fremgangsmåder til at forbedre indføringen af DNA i bakterielle celler
WO2009142770A3 (fr) Compositions et procédés permettant la génération de tissu musculo-squelettique
AR061366A1 (es) Epsp sintasas mejoradas: composiciones y metodos de uso de las mismas
WO2007130642A3 (fr) Modulation du nkg2d

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application